Report cover image

Chronic Wound Care Global Market Report 2025

Published Sep 10, 2025
Length 250 Pages
SKU # BRC20385212

Description

Chronic Wound Care Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chronic wound care market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for chronic wound care ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The chronic wound care market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Product: Advanced Wound Dressing; Surgical Wound Care; Suture And Staples; Tissue Adhesive And Sealants; Anti-infective Dressing; Traditional Wound Care; Wound Therapy Devices

2) By Application: Diabetic Foot Ulcers; Pressure Ulcers; Venous Leg Ulcers; Other Applications

3) By End-User: Hospitals; Clinics; Homecare Settings; Other End-Users

Subsegments:

1) By Advanced Wound Dressing: Hydrocolloid Dressings; Foam Dressings; Alginate Dressings; Hydrofiber Dressings; Collagen Dressings; Film Dressings; Silicone Dressings; Composite Dressings

2) By Surgical Wound Care: Post-operative Dressings; Surgical Drapes; Surgical Sponges; Adhesive Bandages; Hemostatic Agents

3) By Suture And Staples: Absorbable Sutures; Non-Absorbable Sutures; Surgical Staples; Suture Kits

4) By Tissue Adhesive And Sealants: Cyanoacrylate Adhesives; Fibrin Sealants; Collagen-Based Adhesives; Synthetic Polymers

5) By Anti-Infective Dressing: Silver-Based Dressings; Honey-Based Dressings; Iodine-Based Dressings; Antibiotic-Impregnated Dressings

6) By Traditional Wound Care: Gauze Dressings; Bandages; Cotton Wool; Adhesive Plasters; Antiseptic Creams And Ointments

7) By Wound Therapy Devices: Negative Pressure Wound Therapy (NPWT) Devices; Electrical Stimulation Devices; Oxygen Therapy Devices; Infrared Therapy Devices; Ultrasound Therapy Devices

Companies Mentioned: Cardinal Health Inc.; Johnson & Johnson; 3M Company; Medtronic PLC; Becton Dickinson and Company; Stryker Corporation; Teva Pharmaceuticals; Baxter International Inc.; Essity AB (BSN Medical); Medline Industries Inc.; Avery Dennison Corporation; Smith & Nephew PLC; Ethicon Inc.; Coloplast AS; B. Braun Holding GmbH & Co. KG; Paul Hartmann AG; ConvaTec Group PLC; Mölnlycke Health Care AB; Integra LifeSciences Holdings Corporation; Acelity L.P. Inc.; Organogenesis Holdings Inc.; MTF Biologics; MIMEDX Group Inc.; Vericel Corporation; Anika Therapeutics Inc.; Sigvaris Group; Marine Polymer Technologies Inc.; Oneness Biotech Co. Ltd.; Tissue Regenix Group PLC; Alleva Medical Ltd. (Devon Medical Products)

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

250 Pages
1. Executive Summary
2. Chronic Hepatitis B Market Characteristics
3. Chronic Hepatitis B Market Trends And Strategies
4. Chronic Hepatitis B Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Chronic Hepatitis B Growth Analysis And Strategic Analysis Framework
5.1. Global Chronic Hepatitis B PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Chronic Hepatitis B Market Growth Rate Analysis
5.4. Global Chronic Hepatitis B Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Chronic Hepatitis B Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Chronic Hepatitis B Total Addressable Market (TAM)
6. Chronic Hepatitis B Market Segmentation
6.1. Global Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antivirals
Immune Modulators
6.2. Global Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Male
Female
6.3. Global Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Drug Stores And Retail Pharmacies
Online Providers
6.4. Global Chronic Hepatitis B Market, Sub-Segmentation Of Antivirals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nucleos(T)Ide Analogs (Tenofovir, Entecavir)
Interferons (Pegylated Interferon)
6.5. Global Chronic Hepatitis B Market, Sub-Segmentation Of Immune Modulators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immune Checkpoint Inhibitors
Therapeutic Vaccines (HBV Vaccines Under Development)
7. Chronic Hepatitis B Market Regional And Country Analysis
7.1. Global Chronic Hepatitis B Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Chronic Hepatitis B Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Chronic Hepatitis B Market
8.1. Asia-Pacific Chronic Hepatitis B Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Chronic Hepatitis B Market
9.1. China Chronic Hepatitis B Market Overview
9.2. China Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Chronic Hepatitis B Market
10.1. India Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Chronic Hepatitis B Market
11.1. Japan Chronic Hepatitis B Market Overview
11.2. Japan Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Chronic Hepatitis B Market
12.1. Australia Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Chronic Hepatitis B Market
13.1. Indonesia Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Chronic Hepatitis B Market
14.1. South Korea Chronic Hepatitis B Market Overview
14.2. South Korea Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Chronic Hepatitis B Market
15.1. Western Europe Chronic Hepatitis B Market Overview
15.2. Western Europe Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Chronic Hepatitis B Market
16.1. UK Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Chronic Hepatitis B Market
17.1. Germany Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Chronic Hepatitis B Market
18.1. France Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Chronic Hepatitis B Market
19.1. Italy Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Chronic Hepatitis B Market
20.1. Spain Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Chronic Hepatitis B Market
21.1. Eastern Europe Chronic Hepatitis B Market Overview
21.2. Eastern Europe Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Chronic Hepatitis B Market
22.1. Russia Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Chronic Hepatitis B Market
23.1. North America Chronic Hepatitis B Market Overview
23.2. North America Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Chronic Hepatitis B Market
24.1. USA Chronic Hepatitis B Market Overview
24.2. USA Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Chronic Hepatitis B Market
25.1. Canada Chronic Hepatitis B Market Overview
25.2. Canada Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Chronic Hepatitis B Market
26.1. South America Chronic Hepatitis B Market Overview
26.2. South America Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Chronic Hepatitis B Market
27.1. Brazil Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Chronic Hepatitis B Market
28.1. Middle East Chronic Hepatitis B Market Overview
28.2. Middle East Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Chronic Hepatitis B Market
29.1. Africa Chronic Hepatitis B Market Overview
29.2. Africa Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Chronic Hepatitis B Market Competitive Landscape And Company Profiles
30.1. Chronic Hepatitis B Market Competitive Landscape
30.2. Chronic Hepatitis B Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. F Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Merck & Co Inc Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
31. Chronic Hepatitis B Market Other Major And Innovative Companies
31.1. GlaxoSmithKline plc
31.2. Dynavax Technologies Corporation
31.3. Gilead Sciences Inc
31.4. Viatris Inc.
31.5. Teva Pharmaceutical Industries Limited
31.6. Sun Pharmaceutical Industries Ltd.
31.7. Aurobindo Pharma Limited
31.8. Dr. Reddy's Laboratories Ltd.
31.9. Apotex Corp
31.10. Cipla Ltd
31.11. Hikma Pharmaceuticals
31.12. Lupin Pharmaceuticals Inc
31.13. Vir Biotechnology Inc
31.14. VBI Vaccines Inc
31.15. Shenzhen Hepalink Pharmaceutical Co. Ltd.
32. Global Chronic Hepatitis B Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Chronic Hepatitis B Market
34. Recent Developments In The Chronic Hepatitis B Market
35. Chronic Hepatitis B Market High Potential Countries, Segments and Strategies
35.1 Chronic Hepatitis B Market In 2029 - Countries Offering Most New Opportunities
35.2 Chronic Hepatitis B Market In 2029 - Segments Offering Most New Opportunities
35.3 Chronic Hepatitis B Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.